Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
For #BreastCancerAwarenessMonth, our team wanted to share stories about what motivates them to work with us, as we continually strive to provide earlier cancer detection methods to help save lives.#ThinkPink #WhyWeCare #IamAnImagioneer pic.twitter.com/S3Ta8HUGPH
— Imagion Biosystems (@imagionbio) October 12, 2022
Wonder if Proulx is second guessing his crazy idea of having human trials in Australia?
Anyone else think that a U.S. trial would have been completed by now?
No matter how many interviews or events he shows up, the lack of completion of the study is a dark cloud that hovers over his head and not providing some real evidence of what the 5-7 patients outcomes were in terms of the study is just plain stupid or perhaps he has no good news from these patients other than positive toxicology / nanoparticle results?
Until the study is completed, the stock will hover in the 3 cent AUD range, nothing brilliant about that and definitely nothing worth constantly posting about.
I will be back once we have some real news on the study. Otherwise cheers folks.
Good point. Proulx's interviews and promo videos combined with his horrible performance over the last 2 years have driven ibx below 3 cents USD.
IBX already below 3 cents USD. It is at .033 AUD which is .021 USD, One USD = 1.59 AUD,
Another link, more proulx interviews and promotions as first trial now almost 2 years old and still not fully enrolled. Looks like proulx is getting ready for some serious fund raising (and dilution) as, unfortunately, ibx struggles to stay above 3 cents.
Anyone catch the part where proulx says a 2nd trial will be needed - a bigger (and much more expensive) trial. How many years from now might that be completed? 2 years? 5 years? Pity those who bough into the ipo at 20 cents. This stock will be diluted into worthlessness by the time a 2nd trial gets done. How can anyone actually defend the horrible performance of lake tahoe proulx?
Another informative link on where IBX is headed...
Good news for one of IBX's collaborators...
https://globalcancertechnology.com/news/
What a joke. More trials will be needed? They can't even get 15 people to participate in their 1st trial that is almost 2 years old. Burn, burn, burn the cash, no wonder share price is so low.
ibx $.031, on the way to a penny so proulx can issue another billion shares or do a reverse split to finance his Lake Tahoe lifestyle. Meanwhile, can't even enroll 15 people in trial that is almost 2 years old. Who in their right mind would defend this guy?
ibx $.033 and proulx still can't find 15 people for the almost 2 year old trial. But life is good at Lake Tahoe.
Oops, wrong IBX company on previous link, but they do have 2 new jobs for clinical operator and manager even after just filling in 3 other jobs last month.
IBX now has federal funds in helping them to get started...
https://everglade.com/industrial-base-expansion-federal-funding/
ibx $.035, number of patients enrolled in trial that began almost 2 years ago - no one knows for sure but certainly less than 15.
Something to ponder - This supposedly life saving technology has been heralded by mhtx and then ibx for over a decade. It was going to be a moonshot, right around the corner for 10 years. Yet sadly, it still sits in limbo without the design and development of a human instrument being completed. $10's of millions of dollars have come and gone, dozens of p/r's, interviews, videos, promotional campaigns and of course plenty of lobster and winter in Lake Tahoe, all at the expense of investors. Even more incredible, this is not the first rodeo for manny and marv. Look way back and see FDA approval for nano-ti dental implants - another much heralded, much needed healthcare improvement that never saw the light of day. And the gravy train keeps rolling along.
Sure there are risks , where are none anywhere in this world ?
I'm willing to stay in and staying positive.
But...it will and IMHO even higher.
Too much going on and two many partnerships to not produce results..for us real shareholders, this is still a gamble, but one I am still willing to take.
You can's sugarcoat the many, many blemishes of Proulx, but despite that, I still believe in the technology, so I will continue to hold.
But......Can't even hold above 4 cents.
Locked and loaded? With all those shares bought at much higher prices that were supposedly low at the time. Buy low and watch prices go lower and lower not a winning strategy. Remember mhtx a bargain at 2 cents? How about ibx when it was so cheap at 7 cents? By this time next year ALL the cash will be gone and dilution at pennies/share will be rolling out.
Yeah, proulx keeps pumping out partnerships and joint ventures, but where are the revenues? Just following the manny and marv playbook and living the dream on shareholders' money. Burning $10 million/year while still trying to get 15 people enrolled in a study? Something seriously wrong with that picture but I bet it looks good from Lake Tahoe (or from the lobster buffet lol). And what ever happened to the big metals deal? lmao
Ain't worried , Locked and Loaded .The next positive announcement will propel the share $.
Yes, yes and yes, but,
It takes money to play in the cancer space and there were positives in the reports.
MagSense® HER2 breast cancer study interim results released
MagSense® HER2 imaging agent passes stability milestone
Sponsored Research Agreement executed with researchers at Massachusetts General Hospital focuses on MRI
Research collaboration with University of Sydney expands brain cancer project
Move to new facility completed
The Company’s cash balance stood at $8.5 million at end of June 2022, down from $13.4 million at December 2021. Cash will be boosted in Q3 2022 by the expected receipt of $2.5 million in research & development tax incentives from the Australian Taxation Office in respect of its 2021 research & development costs.
In March 2022, the Company released findings from the first five patients in the MagSense® HER2 Breast Cancer Study. Those interim results noted that there had been no safety or tolerability issues reported related to the imaging agent and that there was evidence that the MagSense® imaging agent is successfully reaching the patient’s lymph nodes. To date, results from additional patients enrolled remain consistent with the previously reported findings.
Also during the first half of the year the Company, together with its collaborator Patrys Limited, entered into a research engagement with The University of Sydney related to the potential for the Company’s MagSense® technology to detect brain cancers leveraging the university’s expertise in models of Glioblastoma Multiforme, an aggressive and deadly form of brain cancer. The Company expects to report on the progress of these studies in 2023
A few choice ibx tidbits from 8/24/2022 reports. This is just for 6 months and still can't enroll 15 people in trial now almost 2 years old. Annualize the losses and easy to see that cash is running out in a big way. Gee, I wonder why no one is discussing this stuff:
Revenue Down 90.4% to 265,763
(Loss) Up 297.2% to (5,760,270)
Net (loss) Up 319.5% to (5,374,809)
The Company’s cash balance stood at $8.5 million at end of June 2022, down from $13.4 million at December 2021.
Operating cash outflows increased to $4.8 million for the half-year and the Company’s net loss increased to $5.8 million for the half-year.
Great job proulx, no surprise the stock can't hold above 4 cents. Almost time for another fun winter at Lake Tahoe. Pathetic.
Then why did you ask the question?
Another presentation, another link, and ibx back below 4 cents again. Meanwhile all quiet on the first and worst trial in history. Pathetic. Still blaming Covid? Or did the winter in Lake Tahoe put a freeze on the whole deal?
When it's time to raise more cash, proulx will have a hard time sucking in more investors after his pitiful performance. Lucky to get a penny/share imo.
Imaging collaboration with Patrys Limited mentioned in yesterday's PAB presentation....
https://linksharing.samsungcloud.com/d7gR1e4qKuMu
No Proulx bs for quite some time. Taking a summer break from promo interviews? Or just too embarrassed to face the public as the big trial still can't enroll 15 people even though it will soon be 2 years old. Ridiculous.
No guessing required. manny and marv's actions speak louder than words, clearer than any guessing could ever be. They have scammed investors for many, many years. They don't even bother holding annual meetings or providing regular updates. Look thru the long list of p/r's on the mhtx website and see how almost every one was filled with "forward looking statements" that never quite panned out.
Look at what happened to all the cash from the Flynn technology spinoff. Look at all the consultants that were paid over the years. Then look at how much manny and marv have paid themselves as shareholders value was destroyed. Lock them up.
Your guess is as good as mine.
Again, what seems to be the hold up on this acquisition that has been touted for years and years by marvin?
I don't wish for it. And, yes, current shareholders of MHTX will be on the bottom rung. They'll get a few proportional shares and almost assuredly will be angry.
This scenario has been floated for years. Just what is it that keeps it from happening?
And if it did materialize, what do you think would happen to existing mhtx shares? Surely a profitable company would not want to distribute its profits to 1/2 billion mhtx shares. So reverse split wiping out all current shareholders followed by massive new dilution. Careful what you wish for.
They will merge with a private company and make a new public company with MHTX trading its $70M in accumulated debt for shares in the new company. The new company will be able to write down their profits against the $70M.
What? No link to the so-called new recording? No surprise - even marvin wouldn't have the balls to repeat that acquisition and uplisting nonsense again.
Such bullshit. Scammer Marv has been hyping a major acquisition and uplisting to nasdaq for a decade or more. How does a company do a major acquisition with a few hundred thousand in cash and a stock price struggling to hold above 1 penny?
Where is the link to the actual interview recording you claim was done on 8/9/22? All I saw was a pump and dump promo. Read the disclaimer from the "interviewing" company. Here are just two choice tidbits:
It was actually recorded on 8-9-22.
I'm not sure when they did the interview but the date it was posted was 8-11-22.
I'm providing a link to Marv's mhtx company's theme song performed by Dean Martin.
Click it and start nanodancing.
WTH was this, unprepared, confusing, zero info for shareholders. The guy seems to have the Proulx virus, loves to see himself on video.
Was this by any chance a paid interview?? if it was, they should fire their PR firm.
"wham bang thank you ma'am" misogynistic old man saying nothing.
Zero substance and as a shareholder of IBX, it does not give me any positive vibes. Surely, Bob can do better. LMAO
Sounds like same story he has been spewing for years. How old is that interview?
Here's an interview with Marvelous Marvin that's worth watching. I'll warn you it is filled with a lot of "hopium" that the FDA will eventually approve his nanomedicine technology, the secret company handling the nanometals to make human nanoparts will come to fruition, his plan to have mhtx uplisted to the NASDAQ and the stock price going from pennies a share to dollars a share Right now he admits he has been sitting on his hands but he has never sold a share of mhtx himself. Enjoy!
manhattan-scientifics-eyes-large-acquisition-as-it-continues-to-incubate-transformative-technologies-989901.htmlhttps://www.proactiveinvestors.com/companies/news/989901/manhattan-scientifics-eyes-large-acquisition-as-it-continues-to-incubate-transformative-technologies-989901.html
I see latest 10-Q is out. No wonder it is so quiet around here - absolutely horrible numbers topped off by close to $2 million loss on ibx shares and absolutely no progress on metals business other than burning up the cash as fast as it comes in.
A nice piece put out 8 days ago from the Chief Development Officer of IBX...
A report on progress of these new studies in 2023. Do you thing Proulx will have 15 people enrolled in 1st trial by then? lmao. How many billions of ibx will be outstanding by then? ibx able to hold above 1 penny by then? Currently around 4 cents, down from 20 cents, but keep those links coming and never, ever criticize the ibx situation no matter what..
Another good collaboration with IBX, (Patrys Limited Quarterly Report put out today)...
During the quarter, Patrys expanded its research collaboration with Imagion Biosystems (ASX: IBX). In
May 2021 we first reported initiation of our collaboration with Imagion to explore combination of
Imagion’s MagSense® technology and Patrys’ DNA-targeting PAT-DX1 to develop a highly effective
imaging agent with high specificity for hard-to-diagnose cancers such as brain cancer. Both companies
have recently engaged The University of Sydney to further explore the utility of our combined
technologies as a diagnostic imaging marker in a patient derived animal model of Glioblastoma
Multiforme. We expect to report on the progress of these studies in 2023.
Any progress with the trial that began over 1 1/2 years ago and still hasn't been able to enroll 15 people? This is almost as bad as the FDA approved nano-ti dental implant fiasco. I don't they were able to sell 15 of those implants lol.
I think that they are making progress if IBX, Siemens, and Healthliners are all sponsoring this one...
https://www.linkedin.com/posts/neurosciences-victoria-limited_swinburneuniversity-latrobeuniversity-onjcri-activity-6957535896963330048-r7cV
This is an example of it...
https://www.pr.com/press-release/864948
With this agreement being signed almost 11 months ago here...
Key terms of the Agreement
Statement of WorksThe Agreement is staged into phases with the first two phases being defined. Phase 1 relates to ‘Nanoscintillator Synthesis’ and is expected to have a duration of between 9-12 months with estimated costs of US$450,000-US$500,000. Phase 1 will involve Imagion developing a protocol for synthesizing the yttrium aluminum garnet nanocrystals doped with a praseodymium scintillator.Phase 2 relates to ‘Coating and Linker Chemistries’ and is expected to have a duration of between 9-12 months with estimated costs of US$450,000-US$500,000. Phase 2 will involve Imagion developing surface chemistry to enable a linker (holding a therapeutic payload) to be attached to the nanoscintillator crystals.The estimated costs above include material, labor and any third party or subcontracted costs and will be invoiced by Imagion to GCT. Neither the estimated timing or costs are binding on either party and are included within the Agreement as a guide only and are subject to change. Preliminary works have commenced in relation to Phase 1 of the Agreement
Is the metals technology DOA? Not a word about it for months and latest deal is nearing an end. No wonder mhtx bid is under a penny.
Regarding ibx, time to admit the disconnect between the technology and the share price. Proulx has taken care of that with his poor excuse for Phase I trial and the massive dilution. Post all the links you like, but ibx still struggles to hold the 4 cent level.
Cause they are getting them recognized as being the best nanoparticles in the world. Simply Google search PrecisionMRX and you will find them as the core to new cancer research projects from around the world. Remember any new research treatments that they are part of, they most likely will share in royalties down the line.
Followers
|
84
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
9560
|
Created
|
11/30/05
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |